Boardroom Media (CEO News)
At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Texas based CEO’ operating in the Life Science space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Taylor Schreiber
Chief Executive Officer & Co-founder of Shattuck Labs
Follow Taylor Schreiber:
About Shattuck Labs: Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
David Mittelman
Founder & Chief Executive Officer of Othram
Follow David Mittelman:
About Othram: Othram enables human ID from difficult evidence like touch DNA, mixtures, and decades-old bones.
David Fuller
Chief Executive Officer and Co-Founder of Artificial
David Fuller is the Chief Service Robotics Strategy and R&D officer for KUKA North America. In his role, David is responsible for driving the integration of key IT technology from the cloud, web, and mobiles spaces with the traditional core of KUKA’s operating technologies (OT) in industrial robotics, service robotics, and emerging areas of emphasis such as healthcare and healthcare logistics. David has held previous roles spanning from a professional software engineer to global Vice President of SW R&D with areas of emphasis such as the integration of I/O, deterministic buses, processors and FPGAs and their application within test and measurement in particular. David holds more than 30 patents and was jointly awarded the prestigious 2011 Edith and Peter O’Donnell Award in Technology Innovation from The Academy of Medicine, Engineering and Science of Texas (TAMEST). He graduated cum laude from Texas A&M University in 1995 with a Bachelor’s degree in computer engineering.
Follow David Fuller:
About Artificial, KUKA Robotics: Artificial is a software company that develops a lab automation platform.
RA Session
President, Founder and CEO of Taysha Gene Therapies
RA Session II is the President, CEO and Founder of Taysha Gene Therapies. Mr. Session has nearly 20 years’ experience in the life sciences industry, primarily in business development, corporate strategy and financial roles. Previously, he served as Chief Business Officer of the gene therapy subsidiaries of BridgeBio, as well as Senior Vice President of Corporate Strategy and Business Development at AveXis.
Follow RA Session:
About Taysha Gene Therapies: Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.
Li Chen
Founder & CEO of Hua Medicine
Dr. Li Chen leads Hua Medicine, a drug discovery company whose mission is to bring clinically differentiated medicines to patients in China and worldwide. Before Dr. Chen founded Hua Medicine, he was the Chief Scientific Officer and Head of Research at Roche R&D Center (China) Ltd. and a member of Roche’s Pharma Research Leadership Team. As a founding Director in this position, Li was responsible for development and implementation of China’s drug discovery strategy, creation of the China discovery portfolio, and management of China operations including Biology, Chemistry, Pharmacology, Discovery Technology, Drug Supply and Drug Safety. He developed a “Collaborative Innovation” model through integration of over 100 scientist-based China partnerships with academic institutes, biotech, contract research organizations and clinical development organizations. During his 18 year pharma career, Li also had several leadership positions at Roche Nutley in New Jersey, including head of combinatorial/high throughput chemistry. He is a co-inventor of two Roche drugs that reached Phase II clinical trials in Asthma and in MED. He also served as a member at Roche’s Patent Coordination Committee at Nutley. Li was the President of the Sino-American Pharmaceutical Professionals Association (SAPA) in 2001, and is now a member of the SAPA Board of Directors. He has received numerous honors including the Roche Pharma Olympia Award 2005, Roche D2K Award, and SAPA President’s Award. Most recently, he received IBC China Pharma’s R&D Award, which recognizes outstanding individuals whose contributions changed the landscape, reputation, and ecosystem for drug R&D in China. He has also received the “Shanghai Leading Talent” Award from the Shanghai government. Li received his Ph.D in Chemistry from Iowa State University. He was formerly a lecturer in Organic Chemistry at East China Normal University, and is currently an adjunct professor of Chemical Biology at Tongji University. He has over 70 publications in numerous peer-reviewed scientific journals and in patent literature.
Follow Li Chen:
About Hua Medicine, Tongji University: Hua Medicine is a clinical-stage, innovative drug development company in China.
Brad Knight
CEO of Lighting Science Group
Brad Knight comes to Katerra with over 30 years of hands-on operations, engineering, and supply chain management experience. Before Katerra, he held executive management or board positions at Flextronics and Kymeta as well as served in chief executive, board of director, and executive consultant roles for 1800 Contacts, Erickson Retirement Communities, Retirement Living TV, and Sandisk. He’s managed operations projects within North America, South America, and Asia. Brad holds a BS in Industrial Technology. He has been recognized for creating “One of the Top Ten Places to Work” by Cable World magazine. Brad is a member of the Turnaround Management Association, and served in the U.S. Army Infantry as a Drill Instructor, Master Trainer.
Follow Brad Knight:
About Lighting Science Group, Riverwood Solutions: Lighting Science Group designs, develops, manufactures, and markets general illumination products that use light-emitting diodes.
Miguel Calatayud
Chief Executive Officer of iwi Life
Has over 18 years of experience in the food and beverage and health and wellness industries. As a founder of two start-ups and leader of world class mid-size companies, he brings extensive expertise in general management, agriculture, R&D and global marketing and sales. He has earned an Executive MBA from ComillasPontifical University, a Master of Global Logistics from ICIL, an Executive Master of Finance from ESIC and a Harvard Business School President’s Program.
Follow Miguel Calatayud:
About iwi Life: Iwi Life is a rural-focused manufacturer of algae-based nutrition that is advantageous to any living organism.
Daniel Timms
Founder, CEO and CTO of BiVACOR
Daniel Timms, PhD, is the founder of BiVACOR, Inc. A graduate of the Queensland University of Technology, Dr. Timms completed his postdoctoral training at The Prince Charles Hospital’s cardiac transplant center in Brisbane, Australia, and at the Helmholtz Institute in Aachen, Germany, one of Europe’s leading cardiovascular device research centers. He has more than 15 years of experience in mechanical circulatory support development.
Follow Daniel Timms:
About BiVACOR: BiVACOR designs and manufactures centrifugal heart pumps.
Rafael Rosengarten
CEO of Genialis
Follow Rafael Rosengarten:
About Genialis, Genialis: Genialis tackles diseases of unmet need with in silico precision medicine, blending compbio & AI for translational & clinical discovery.
Clark Jernigan
CEO of Vuv Analytics
Clark has a successful track record in leading and developing early stage ventures, specializing in hardware, clean tech, and technology service companies. His 25+ year management career includes Venture Partner at Austin Ventures, VP/General Manager and Director of Engineering at Cirrus Logic, product development engineering and management at AMD, and equity research at Alex Brown. Clark holds an MBA from the Kellogg Graduate School of Management at Northwestern University, a Master’s of Electrical Engineering from Rice University, and a BS in Electrical Engineering from Texas A&M University.
Follow Clark Jernigan:
About Vuv Analytics: VUV Analytics develops vacuum ultraviolet optical technologies available for use in the life and environmental sciences.
Douglas Baum
Co-Founder, Chief Executive Officer, Director & President of QSAM Biosciences
Follow Douglas Baum:
About QSAM Biosciences: QSAM Biosciences is a developer of nuclear medicines for the treatment of cancer and related diseases and conditions.
Bill Jackson
Founder , CSO & CEO of Base Pair Biotechnologies
Follow Bill Jackson:
About Base Pair Biotechnologies: custom aptamer development services
